486 related articles for article (PubMed ID: 25161895)
61. Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders.
Liang R; Zheng L; Ji T; Zheng J; Liu J; Yuan C; Huang Q; Yang M
Lupus; 2022 Feb; 31(2):187-193. PubMed ID: 35042378
[TBL] [Abstract][Full Text] [Related]
62. Functional Connectivity Changes in Systemic Lupus Erythematosus: A Resting-State Study.
Nystedt J; Mannfolk P; Jönsen A; Bengtsson A; Nilsson P; Sundgren PC; Strandberg TO
Brain Connect; 2018 May; 8(4):220-234. PubMed ID: 29498293
[TBL] [Abstract][Full Text] [Related]
63. Fatigue and cognitive function in systemic lupus erythematosus: associations with white matter microstructural damage. A diffusion tensor MRI study and meta-analysis.
Wiseman SJ; Bastin ME; Hamilton IF; Hunt D; Ritchie SJ; Amft EN; Thomson S; Belch JF; Ralston SH; Wardlaw JM
Lupus; 2017 May; 26(6):588-597. PubMed ID: 27687026
[TBL] [Abstract][Full Text] [Related]
64. Brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus with new acute neurological symptoms.
Welsh RC; Rahbar H; Foerster B; Thurnher M; Sundgren PC
J Magn Reson Imaging; 2007 Sep; 26(3):541-51. PubMed ID: 17729344
[TBL] [Abstract][Full Text] [Related]
65. Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT.
Abreu MR; Jakosky A; Folgerini M; Brenol JC; Xavier RM; Kapczinsky F
Clin Imaging; 2005; 29(3):215-21. PubMed ID: 15855069
[TBL] [Abstract][Full Text] [Related]
66. Features of hyperintense white matter lesions and clinical relevance in systemic lupus erythematosus.
Guo Q; He Y; Liu X; Gao X; Xu J; Li X; Sun Y; Xiang Y; Li R; Li Z
Chin Med J (Engl); 2022 Apr; 135(8):962-970. PubMed ID: 35730373
[TBL] [Abstract][Full Text] [Related]
67. Neuropsychiatric lupus in Malaysian children: clinical characteristics, imaging features and 12-month outcomes.
Lim SC; Md-Yusof YL; Johari B; Abdul-Kadir RF; Tang SP
Turk J Pediatr; 2021; 63(5):743-751. PubMed ID: 34738356
[TBL] [Abstract][Full Text] [Related]
68. White matter integrity in schizophrenia and bipolar disorder: Tract- and voxel-based analyses of diffusion data from the Connectom scanner.
Mamah D; Ji A; Rutlin J; Shimony JS
Neuroimage Clin; 2019; 21():101649. PubMed ID: 30639179
[TBL] [Abstract][Full Text] [Related]
69. Performances of diffusion kurtosis imaging and diffusion tensor imaging in detecting white matter abnormality in schizophrenia.
Zhu J; Zhuo C; Qin W; Wang D; Ma X; Zhou Y; Yu C
Neuroimage Clin; 2015; 7():170-6. PubMed ID: 25610778
[TBL] [Abstract][Full Text] [Related]
70. Brain morphology and cortical thickness variations in systemic lupus erythematosus patients: Differences among neurological, psychiatric, and nonneuropsychiatric manifestations.
Zimmermann N; Goulart Corrêa D; Tukamoto G; Netto T; Batista Pereira D; Paz Fonseca R; Gasparetto EL
J Magn Reson Imaging; 2017 Jul; 46(1):150-158. PubMed ID: 27862544
[TBL] [Abstract][Full Text] [Related]
71. Fluid Attenuated Inversion Recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus.
Sibbitt WL; Schmidt PJ; Hart BL; Brooks WM
J Rheumatol; 2003 Sep; 30(9):1983-9. PubMed ID: 12966602
[TBL] [Abstract][Full Text] [Related]
72. Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus.
Jia J; Xie J; Li H; Wei H; Li X; Hu J; Meng D; Zhang Y; Zhang X
Lupus; 2019 Aug; 28(9):1128-1133. PubMed ID: 31315530
[TBL] [Abstract][Full Text] [Related]
73. Neuropsychiatric systemic lupus erythematosus: association with global disease activity.
Morrison E; Carpentier S; Shaw E; Doucette S; Hanly JG
Lupus; 2014 Apr; 23(4):370-7. PubMed ID: 24457602
[TBL] [Abstract][Full Text] [Related]
74. Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus.
Gueye M; Preziosa P; Ramirez GA; Bozzolo EP; Canti V; Margoni M; Meani A; Moiola L; Rovere-Querini P; Manfredi AA; Filippi M; Rocca MA
Mol Psychiatry; 2024 Feb; 29(2):359-368. PubMed ID: 38036603
[TBL] [Abstract][Full Text] [Related]
75. Diffusion tensor imaging and ventricle volume quantification in patients with chronic shunt-treated hydrocephalus: a matched case-control study.
Tan K; Meiri A; Mowrey WB; Abbott R; Goodrich JT; Sandler AL; Suri AK; Lipton ML; Wagshul ME
J Neurosurg; 2018 Dec; 129(6):1611-1622. PubMed ID: 29350598
[TBL] [Abstract][Full Text] [Related]
76. Retinal nerve fiber layer and macular thinning in systemic lupus erythematosus: an optical coherence tomography study comparing SLE and neuropsychiatric SLE.
Liu GY; Utset TO; Bernard JT
Lupus; 2015 Oct; 24(11):1169-76. PubMed ID: 25888613
[TBL] [Abstract][Full Text] [Related]
77. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
[TBL] [Abstract][Full Text] [Related]
78. Multimodal imaging in systemic lupus erythematosus patients with diffuse neuropsychiatric involvement.
Zivadinov R; Shucard JL; Hussein S; Durfee J; Cox JL; Bergsland N; Dwyer MG; Benedict RH; Ambrus J; Shucard DW
Lupus; 2013 Jun; 22(7):675-83. PubMed ID: 23640981
[TBL] [Abstract][Full Text] [Related]
79. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
[TBL] [Abstract][Full Text] [Related]
80. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
